Matthew Diamond, MD, PhD
Chief Medical Officer for Digital Health, Digital Health Center of Excellence, Center for Devices and Radiological Health, Office of Strategic Partnerships and Technology Innovation
Matthew Diamond, MD, PhD is the Chief Medical Officer for Digital Health at FDA's Center for Devices and Radiological Health (CDRH), where he is the senior clinical expert and focal point of contact for digital health medical devices and related clinical issues. In his role at FDA, Dr. Diamond oversees digital health policy development and implementation for emerging technologies including artificial intelligence and medical device software. Since March 2020, Dr. Diamond has been a leader on CDRH’s COVID-19 response team. Prior to joining the Agency, Dr. Diamond served on leadership teams of large and small technology companies, including as Chief Medical Officer at Nokia, and as Medical Director at Fossil Group and the startup Misfit Wearables. He was Vice Chair of the Consumer Technology Association (CTA) Health & Fitness Technology Board of Directors, where he promoted public health applications of mobile technology and established an ANSI-accredited standardization committee to develop standards in digital health for wellness-related hardware and mobile applications. Dr. Diamond served on numerous advisory boards including at the Center for Personalized Health Monitoring at UMass Amherst and for the venture firm NGP Capital. He earned his MD and PhD (biophysics) from the Mount Sinai School of Medicine, and he is board certified in rehabilitation medicine and sports medicine and certified in medical acupuncture. A faculty member at NYU, Dr. Diamond is passionate about helping people improve their mobility and performance through a holistic approach to rehabilitation and technology that promotes wellness.